Connor, Clark & Lunn Investment Management Ltd. Sutro Biopharma, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 437,051 shares of STRO stock, worth $804,173. This represents 0.01% of its overall portfolio holdings.
Number of Shares
437,051Holding current value
$804,173% of portfolio
0.01%Shares
10 transactions
Others Institutions Holding STRO
# of Institutions
137Shares Held
62.4MCall Options Held
77.1KPut Options Held
31.4K-
Suvretta Capital Management, LLC New York, NY7.19MShares$13.2 Million0.98% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$12.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.2MShares$7.72 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3MShares$5.52 Million0.03% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.83MShares$5.21 Million1.53% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $96M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...